Isabel Aznarez
Founder at STOKE THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Seth Harrison | M | 63 | 9 years | |
| Huw Nash | M | 57 | 10 years | |
| Adrian Krainer | M | 65 | 10 years | |
| Arthur Levin | M | 70 | 9 years | |
| Arthur Tzianabos | M | 60 | 6 years | |
| Edward Kaye | M | 74 | 7 years | |
| Ian Smith | M | 58 | 1 years | |
| Jonathan Allan | M | - | - | |
| Garry Menzel | M | 59 | 4 years | |
| Julie Smith | F | 53 | 4 years | |
| Jennifer Burstein | F | 52 | 5 years | |
| Doug Snow | M | - | 3 years | |
| Annemieke Aartsma-Rus | M | - |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Shalini Andersson | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Jonathan K. Watts | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Steven Dowdy | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Paloma H. Giangrande | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Frank Rigo | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Barry Ticho | M | 64 | 7 years | |
| Jeffrey Foy | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Laura Sepp-Lorenzino | M | 63 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Shamim Ruff | F | 64 | 6 years | |
| I. Anita Anand | F | - |
University of Toronto
| 18 years |
| Anita Anand | F | - |
University of Toronto
| 18 years |
| Marie Wikström Lindholm | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | 2 years |
| Richard Geary | M | 66 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Joan Wood | F | - | 5 years | |
| Takanori Yokota | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Marc M. Lemaître | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Dawn Kalmar | F | 47 | 5 years | |
| Eric Rojas | M | - | - | |
| Catherine J. Riggall | F | - |
University of Toronto
| 20 years |
| Ian MacLachlan | M | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | - |
| Chaim Goldreich | M | 58 |
University of Toronto
| 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stefan Ioannou | M | - |
University of Toronto
| 10 years |
| Tom Keefe | M | - |
University of Toronto
| 5 years |
| Tom Rand | M | - |
University of Toronto
| 5 years |
| Peter Van Michaels | M | - |
University of Toronto
| 7 years |
| Bryan Edwin Rock | M | 45 |
University of Toronto
| 7 years |
| Michael Dolega | M | - |
University of Toronto
| 7 years |
| Brendan Cochrane | M | - |
University of Toronto
| 7 years |
| Kamyar Hazaveh | M | - |
University of Toronto
| 4 years |
| Andrzej Jankowski | M | - |
University of Toronto
| 9 years |
| Claudia Krywiak | M | - |
University of Toronto
| 3 years |
| Ka Ho Yu | M | 44 |
University of Toronto
| 7 years |
| Yousef Rehman | M | 42 |
University of Toronto
| 7 years |
| Zachary Newton | M | 40 |
University of Toronto
| 4 years |
| Robin A. Walker | M | 55 | 1 years | |
| Ricky Mehra | M | 45 |
University of Toronto
| 7 years |
| Florin Predescu VasvarI | M | 45 |
University of Toronto
| 5 years |
| David Toffoli | M | - |
University of Toronto
| 4 years |
| Yuri Sagalov | M | - |
University of Toronto
| 5 years |
| Nancy M. Wyant | F | - | 5 years | |
| Meny Grauman | M | - |
University of Toronto
| 6 years |
| Ryan Q. Fang | M | - |
University of Toronto
| 5 years |
| Krystal Nagel | F | - |
University of Toronto
| 4 years |
| Rusty Wong | M | - |
University of Toronto
| 6 years |
| Grant Connor | M | - |
University of Toronto
| 4 years |
| Adam Cilio | M | - |
University of Toronto
| 6 years |
| Alfred C. Sum | M | - |
University of Toronto
| 6 years |
| Jason Wong | M | - |
University of Toronto
| 4 years |
| Martine Becker | F | - |
University of Toronto
| 2 years |
| Suk Man Chan | F | 44 |
University of Toronto
| 4 years |
| Jamie Leung | M | - |
University of Toronto
| 3 years |
| Tamer Azer | M | - |
University of Toronto
| 4 years |
| Yernat Berdigulov | M | 37 |
University of Toronto
| 4 years |
| Rong Zhang | M | 39 |
University of Toronto
| 3 years |
| Rakesh V. Advani | M | - |
University of Toronto
| 4 years |
| Calvin Marks | M | - |
University of Toronto
| 4 years |
| Tanya Sam | F | - |
University of Toronto
| 2 years |
| Jennifer Renda | F | - |
University of Toronto
| 4 years |
| Matthew Harvey Sanders | M | - |
University of Toronto
| 5 years |
| Louis Derlis | M | - |
University of Toronto
| 4 years |
| Heather Herron | F | - |
University of Toronto
| 4 years |
| Elizabeth van Monsjou | F | - |
University of Toronto
| 5 years |
| David Lau | M | 39 |
University of Toronto
| 4 years |
| Matthew Johnston | M | - |
University of Toronto
| 4 years |
| Andre McDonald | M | - |
University of Toronto
| 3 years |
| Nicholas Wood | M | - |
University of Toronto
| 2 years |
| Gloria Woo | M | - |
University of Toronto
| 5 years |
| Chris Lee | M | - |
University of Toronto
| 2 years |
| Daniel Carabajal | M | - |
University of Toronto
| 2 years |
| Kasia Pawluk | F | - |
University of Toronto
| 4 years |
| Kristin G. Ali | F | - |
University of Toronto
| 4 years |
| Rebecca Dyers | F | - |
University of Toronto
| 4 years |
| Elena Gorbatkova | F | - |
University of Toronto
| 4 years |
| David S. Lambie | M | - |
University of Toronto
| 1 years |
| Jillani Jahangir | M | - |
University of Toronto
| 4 years |
| Steve Choi | M | - |
University of Toronto
| 4 years |
| Jon Case | M | - |
University of Toronto
| 4 years |
| Chris Blumas | M | - |
University of Toronto
| 2 years |
| Asya Abramyan | F | - |
University of Toronto
| 5 years |
| Yiling Chen | F | - |
University of Toronto
| 4 years |
| Klara Gotz | F | - |
University of Toronto
| 4 years |
| Tom Tran | M | - |
University of Toronto
| 4 years |
| Paul Chavez | M | - |
University of Toronto
| 4 years |
| Sarah Fang | F | - |
University of Toronto
| 2 years |
| Rajbir Gill | M | - |
University of Toronto
| 5 years |
| Ronan Levy | M | 45 |
University of Toronto
| 3 years |
| Lori-Ann Christie | M | - |
University of Toronto
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 68 | 68.00% |
| United States | 32 | 32.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Isabel Aznarez
- Personal Network
